FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089640735> ?p ?o ?g. }

• W2089640735 endingPage "698" @default.
• W2089640735 startingPage "693" @default.
• W2089640735 abstract "Asthma guidelines recommend increasing or doubling inhaled corticosteroid (ICS) dose to treat mild and moderate exacerbations of asthma in adults.To: (i) compare the effectiveness of doubling existing daily ICS dose (fluticasone) with maintaining usual ICS dose and usual daily ICS dose accompanied by oral steroids (OS) (dexamethasone) during mild and moderately severe exacerbations of asthma in adults; (ii) examine determinants of success and failure; and (iii) compare side-effect profiles.A randomized, double-blind, placebo-controlled (double-dummy), triple crossover trial. Participants acted as their own control. Outcome measures included treatment success/failure, peak expiratory flow (PEF) after 7 days therapy or at treatment failure, and side-effects.From 22 participants (nine males and 13 females), 18 pairs of data were available for maintaining usual ICS versus doubling ICS and doubling ICS versus OS, and 19 for maintaining usual ICS versus OS. Median (fifth-95th percentile) age was 46.5 (32-64) years and forced expiratory volume in one second (FEV(1)) 73% (29-97%) predicted. The outcome after doubling ICS was not superior to maintaining usual ICS, with 11 (61%) failures in both arms (P = 0.66). OS, with only 5 (26%) failures, was superior to maintaining usual ICS with 12 (63%) failures (P = 0.04), and to doubling ICS with 5 (28%) versus 11 (61%) failures (P = 0.07). Median PEF (as percentage of run-in best) at end-points were 90.5% (57.1-177.1) for OS, 78.3% (39.5-103.1) for maintaining usual ICS and 77.9 (27.7-110.3) for doubling ICS. Neither gender nor PEF at exacerbation were predictive of failure. Although doubling ICS was not an effective therapy overall, ICS dose at exacerbation were predictive of success in the doubling ICS arm (P = 0.04). Treatment failures when doubling daily ICS dose were more common if achieved fluticasone dose was less than 2000 microg (three of 11, 73%) compared to 2000 microg or greater (eight of eight, 37.5%). Increasing age and the presence of an upper respiratory tract infection (URTI) were predictive of failure with OS. Side-effects were more commonly reported with OS (52.6%) than doubling ICS (42.1%) or maintaining usual ICS (19.1%) with the most common being mood changes (36.8%), sleep disturbance (31.6%) and changes in appetite (26.3%).Doubling daily ICS dose per se is not effective for the treatment of mild to moderately severe exacerbations of asthma in adults. Success may depend on achieved ICS dose. Oral steroids are effective, but side-effects are common. A review of current guidelines may be warranted." @default.
• W2089640735 created "2016-06-24" @default.
• W2089640735 creator A5000295617 @default.
• W2089640735 creator A5022270548 @default.
• W2089640735 creator A5033155832 @default.
• W2089640735 creator A5037742032 @default.
• W2089640735 date "2005-11-25" @default.
• W2089640735 modified "2023-10-10" @default.
• W2089640735 title "Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults" @default.
• W2089640735 cites W1480339713 @default.
• W2089640735 cites W1812633805 @default.
• W2089640735 cites W1968945837 @default.
• W2089640735 cites W1979554096 @default.
• W2089640735 cites W1983955745 @default.
• W2089640735 cites W2026218645 @default.
• W2089640735 cites W2040948705 @default.
• W2089640735 cites W2051791830 @default.
• W2089640735 cites W2061476722 @default.
• W2089640735 cites W2061941095 @default.
• W2089640735 cites W2097208648 @default.
• W2089640735 cites W2100891719 @default.
• W2089640735 cites W2117904842 @default.
• W2089640735 cites W2137116971 @default.
• W2089640735 cites W2138040883 @default.
• W2089640735 cites W2157753690 @default.
• W2089640735 cites W4253159029 @default.
• W2089640735 cites W48370510 @default.
• W2089640735 cites W1967155454 @default.
• W2089640735 doi "https://doi.org/10.1111/j.1445-5994.2005.00972.x" @default.
• W2089640735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16313543" @default.
• W2089640735 hasPublicationYear "2005" @default.
• W2089640735 type Work @default.
• W2089640735 sameAs 2089640735 @default.
• W2089640735 citedByCount "36" @default.
• W2089640735 countsByYear W20896407352012 @default.
• W2089640735 countsByYear W20896407352014 @default.
• W2089640735 countsByYear W20896407352015 @default.
• W2089640735 countsByYear W20896407352016 @default.
• W2089640735 countsByYear W20896407352017 @default.
• W2089640735 countsByYear W20896407352019 @default.
• W2089640735 countsByYear W20896407352022 @default.
• W2089640735 crossrefType "journal-article" @default.
• W2089640735 hasAuthorship W2089640735A5000295617 @default.
• W2089640735 hasAuthorship W2089640735A5022270548 @default.
• W2089640735 hasAuthorship W2089640735A5033155832 @default.
• W2089640735 hasAuthorship W2089640735A5037742032 @default.
• W2089640735 hasConcept C105795698 @default.
• W2089640735 hasConcept C122048520 @default.
• W2089640735 hasConcept C126322002 @default.
• W2089640735 hasConcept C142724271 @default.
• W2089640735 hasConcept C185592680 @default.
• W2089640735 hasConcept C202751555 @default.
• W2089640735 hasConcept C204787440 @default.
• W2089640735 hasConcept C27081682 @default.
• W2089640735 hasConcept C2776042228 @default.
• W2089640735 hasConcept C2776804153 @default.
• W2089640735 hasConcept C2780401358 @default.
• W2089640735 hasConcept C2781212218 @default.
• W2089640735 hasConcept C33923547 @default.
• W2089640735 hasConcept C48900799 @default.
• W2089640735 hasConcept C55493867 @default.
• W2089640735 hasConcept C71924100 @default.
• W2089640735 hasConceptScore W2089640735C105795698 @default.
• W2089640735 hasConceptScore W2089640735C122048520 @default.
• W2089640735 hasConceptScore W2089640735C126322002 @default.
• W2089640735 hasConceptScore W2089640735C142724271 @default.
• W2089640735 hasConceptScore W2089640735C185592680 @default.
• W2089640735 hasConceptScore W2089640735C202751555 @default.
• W2089640735 hasConceptScore W2089640735C204787440 @default.
• W2089640735 hasConceptScore W2089640735C27081682 @default.
• W2089640735 hasConceptScore W2089640735C2776042228 @default.
• W2089640735 hasConceptScore W2089640735C2776804153 @default.
• W2089640735 hasConceptScore W2089640735C2780401358 @default.
• W2089640735 hasConceptScore W2089640735C2781212218 @default.
• W2089640735 hasConceptScore W2089640735C33923547 @default.
• W2089640735 hasConceptScore W2089640735C48900799 @default.
• W2089640735 hasConceptScore W2089640735C55493867 @default.
• W2089640735 hasConceptScore W2089640735C71924100 @default.
• W2089640735 hasIssue "12" @default.
• W2089640735 hasLocation W20896407351 @default.
• W2089640735 hasLocation W20896407352 @default.
• W2089640735 hasOpenAccess W2089640735 @default.
• W2089640735 hasPrimaryLocation W20896407351 @default.
• W2089640735 hasRelatedWork W1550559433 @default.
• W2089640735 hasRelatedWork W1982434602 @default.
• W2089640735 hasRelatedWork W2066474499 @default.
• W2089640735 hasRelatedWork W2090722260 @default.
• W2089640735 hasRelatedWork W2118590544 @default.
• W2089640735 hasRelatedWork W2354241142 @default.
• W2089640735 hasRelatedWork W3029340634 @default.
• W2089640735 hasRelatedWork W30732517 @default.
• W2089640735 hasRelatedWork W3112702890 @default.
• W2089640735 hasRelatedWork W2189235034 @default.
• W2089640735 hasVolume "35" @default.
• W2089640735 isParatext "false" @default.
• W2089640735 isRetracted "false" @default.
• W2089640735 magId "2089640735" @default.
• W2089640735 workType "article" @default.